Cao Han PHD 4
4 · BioNano Genomics, Inc · Filed Aug 27, 2018
Insider Transaction Report
Form 4
Cao Han PHD
Chief Scientific Officer
Transactions
- Conversion
Common Stock
2018-08-23+5,941→ 7,354 total - Conversion
Series C Convertible Preferred Stock
2018-08-23−52,720→ 0 total→ Common Stock (1,231 underlying) - Conversion
Series D-1 Convertible Preferred Stock
2018-08-23−104,167→ 0 total→ Common Stock (2,433 underlying) - Conversion
Common Stock
2018-08-23+1,231→ 8,585 total - Conversion
Series B Convertible Preferred Stock
2018-08-23−254,275→ 0 total→ Common Stock (5,941 underlying) - Conversion
Common Stock
2018-08-23+101,918→ 110,503 total - Conversion
Common Stock
2018-08-23+2,433→ 112,936 total - Conversion
Series D Convertible Preferred Stock
2018-08-23−4,362,062→ 0 total→ Common Stock (101,918 underlying)
Footnotes (1)
- [F1]Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date.